Andina Acquisition Corp Price, Forecast, Insider, Ratings, Fundamentals & Signals

– expected closing date of july 20, 2021 –

New york, feb. 25, 2021 /prnewswire/ -- if you own shares in any of the companies listed above and would like to discuss our investigations or have any questions concerning this notice or your rights or interests, please contact: joshua rubin, esq. weisslaw llp 1500 broadway, 16th floor...

New york, jan. 28, 2021 /prnewswire/ -- weisslaw llp is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of andina acquisition corp. iii ("andina" or the "company") (nasdaq: anda) in connection with the company's proposed merger with...

New york, nov. 04, 2020 (globe newswire) -- andina acquisition corp. iii (nasdaq: anda, andaw, and andau) (“andina”) and emmac life sciences limited (“emmac”) announce that they have today mutually terminated negotiations regarding the proposed business combination between the parties, pursuant to which emmac was expected to become a publicly traded company on the nasdaq stock market.

New york, oct. 28, 2020 (globe newswire) -- andina acquisition corp. iii (nasdaq: anda, andaw, and andau) (“andina” or the “company”) today announced that the company's shareholders have voted to adjourn the meeting for the consideration of extending the date by which andina must consummate a business combination from october 31, 2020 (or december 31, 2020 if andina has executed a definitive agreement for a business combination by october 31, 2020) to january 31, 2021 (or april 30, 2021 if andina has executed a definitive agreement for a business combination by january 31, 2021) (the “proposed extension”) to a later date or dates to be determined by the company's board of directors...

– Expected Closing Date of July 20, 2021 –

NEW YORK, Feb. 25, 2021 /PRNewswire/ -- If you own shares in any of the companies listed above and would like to discuss our investigations or have any questions concerning this notice or your rights or interests, please contact: Joshua Rubin, Esq. WeissLaw LLP 1500 Broadway, 16th Floor...

NEW YORK, Jan. 28, 2021 /PRNewswire/ -- WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Andina Acquisition Corp. III ("Andina" or the "Company") (NASDAQ: ANDA) in connection with the Company's proposed merger with...

NEW YORK, Nov. 04, 2020 (GLOBE NEWSWIRE) -- Andina Acquisition Corp. III (NASDAQ: ANDA, ANDAW, and ANDAU) (“Andina”) and EMMAC Life Sciences Limited (“EMMAC”) announce that they have today mutually terminated negotiations regarding the proposed business combination between the parties, pursuant to which EMMAC was expected to become a publicly traded company on the NASDAQ Stock Market.

NEW YORK, Oct. 28, 2020 (GLOBE NEWSWIRE) -- Andina Acquisition Corp. III (NASDAQ: ANDA, ANDAW, and ANDAU) (“Andina” or the “Company”) today announced that the Company's shareholders have voted to adjourn the meeting for the consideration of extending the date by which Andina must consummate a business combination from October 31, 2020 (or December 31, 2020 if Andina has executed a definitive agreement for a business combination by October 31, 2020) to January 31, 2021 (or April 30, 2021 if Andina has executed a definitive agreement for a business combination by January 31, 2021) (the “Proposed Extension”) to a later date or dates to be determined by the Company's board of directors...

NEW YORK, Oct. 28, 2020 (GLOBE NEWSWIRE) -- Andina Acquisition Corp. III (NASDAQ: ANDA, ANDAW, and ANDAU) (“Andina” or the “Company”) today announced that the Company's board of directors has determined to postpone the vote by its shareholders on extending the date by which Andina must consummate a business combination from October 31, 2020 (or December 31, 2020 if Andina has executed a definitive agreement for a business combination by October 31, 2020) to January 31, 2021 (or April 30, 2021 if Andina has executed a definitive agreement for a business combination by January 31, 2021) (the “Proposed Extension”).

EMMAC is the Largest Independent European Cannabis Company with Low-Cost Cultivation, EU-GMP Manufacturing and Processing, and an Import / Distribution Network in all Key European Markets EMMAC is the Largest Independent European Cannabis Company with Low-Cost Cultivation, EU-GMP Manufacturing and Processing, and an Import / Distribution Network in all Key European Markets

LONDON, Aug. 18, 2020 (GLOBE NEWSWIRE) -- EMMAC Life Sciences Group (”EMMAC” or the “Group” or the “Company”), Europe’s largest independent cannabis company, is pleased to announce that EMMAC SAGL, the Group’s pharmaceutical entity in  Switzerland, has secured its Good Distribution Practice (“GDP”) licence for the distribution of medicinal products. EMMAC now has the ability to import, distribute and export medicinal products, including medical cannabis, for the domestic Swiss, EU and international markets.  EMMAC currently holds multiple research, cultivation and GMP licences across its vertically integrated business in Europe, which is experiencing increasing demand for premium-quality medical cannabis products...

Spanish EU GMP Facility now has licences to cultivate, extract and manufacture cannabis extract  EMMAC now licensed to cultivate medical cannabis in Portugal and Spain  LONDON, July 28, 2020 (GLOBE NEWSWIRE) -- EMMAC Life Sciences Group, Europe’s largest independent cannabis company, is pleased to announce that Medalchemy, the Group’s Good Manufacturing Practice (“GMP”) certified manufacturing site in Alicante, Spain has secured approval from the Spanish Health Authorities (“AEMPS”) to cultivate medical cannabis. Medalchemy now has fully integrated cannabis supply facilities, with a licence to grow medical cannabis commercially as well as extract and manufacture cannabis extract as an active pharmaceutical ingredient (“API”)...

EMMAC is the Largest Independent European Cannabis Company with Low-Cost Cultivation, EU-GMP Manufacturing and Processing, and an Import / Distribution Network in all Key European MarketsNEW YORK and LONDON, July 24, 2020 (GLOBE NEWSWIRE) -- Andina Acquisition Corp. III (NASDAQ: ANDA, ANDAW, and ANDAU) (“Andina”) and EMMAC Life Sciences Limited (“EMMAC”) jointly announced that the companies will host a Zoom webcast and conference call at 11:00 AM ET today to discuss their non-binding letter of intent (the “LOI”) for a business combination, pursuant to which EMMAC would become a publicly traded company on the NASDAQ Stock Market. As consideration for the transaction, it is anticipated that the current EMMAC shareholders would collectively own a majority of the equity of the combined public company...